In Japan, the revision of the Copyright Act and the Unfair Competition Prevention Act has been made toward the use of artificial intelligence (AI) and data. The Ministry of Economy, Trade, and Industry have issued "Contract guidelines on the use of AI data" and other rules are being developed. In the medical field, in addition to these general rules, it is important to protect patient rights and to protect intellectual property for appropriate evaluation of medical personnel for data creation.